The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines

Cancer Chemotherapy and Pharmacology

Volumn 59, Issue 6, 2007, Pages 781-787

  Balcer Kubiczek, Elizabeth K ^a,b   Attarpour, Mona ^a   Edelman, Martin J ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Apoptosis; Cell cycle; Dimemethylamino benzoylphenylurea (BPU); Histone H2AX phosphorylation; Lung carcinoma; X irradiation

Indexed keywords

HISTONE H2A; N [4 (5 BROMO 2 PYRIMIDYLOXY) 3 METHYLPHENYL]DIMETHYLAMINOBENZOYLPHENYLUREA; NSC 639829; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIZATION; X IRRADIATION; X RAY;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL SURVIVAL; COMBINED MODALITY THERAPY; DNA DAMAGE; HUMANS; LUNG NEOPLASMS; METHYLUREA COMPOUNDS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 33947311186     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0333-3     Document Type: Article

References (30)

1. Abal M, Andreu JM, Barasoain I (2003) Taxanes: microtubule and centrosome targets, and cell cycle-dependent mechanisms of action. Curr Cancer Drug Targets 3:1993-2003
2. Abdel-Aziz W, Hickey R, Edelman M et al (2003) Effect of novel benzoylphenylurea derivatives on DNA polymerase alpha activity using the synthesome-based in vitro model system. Invest New Drugs 21:421-428
3. Abdel-Aziz W, Malkas LH, Wills PW et al (2003) The DNA synthesome: its potential as a novel in vitro model system for studying S-phase specific anticancer agents. Crit Rev Oncol Hematol 48:19-33
4. Ando N, Nakajima T, Masuda H et al (1995) Antimicrobule effects of the novel antitumor benzoylphenylurea derivative HO-221. Cancer Chemother Pharmacol 37:63-69
5. Balcer-Kubiczek EK, Zhang XF, Harrison GH et al (1999) Delayed expression of hpS2 and prolonged expression of Cip1/Waf1/Sdi1 in human tumor cells irradiated with X-rays, Wssion neutrons or 1 GeV/nucleon Fe ions. Int J Radiat Biol 75:529-541
6. Balcer-Kubiczek EK, Attarpour M, Kennedy AS et al (2006) Cytotoxicity of docetaxel (Taxotere®) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells. Chemotherapy 52:231-240
7. Chou T-C (1994) Assessment of synergistic and antagonistic effects of chemotherapeutic agents in vitro. In: Kochli OR, Sevin B-U, Haller U (eds) Chemosensitivity testing in gynecologic malignancies and breast cancer. Contrib Gynecol Obstet. Basel, Karger 19:91-107
8. Cox JD, Azarnia N, Byhardt RW, Shin KH et al (1991) N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Biol Oncol Biol Phys 20:7-12
9. Curran WJ, Scott C, Langer G et al (2000) Phase III comparison of sequential vs concurrent chemoradiation for patients with nonresectable stage III non-small cell lung cancer. Initial report of RTOG 9410. Proc Am Soc Clin Oncol 19:484a
10. Dillman RO, Seagren SL, Propert KJ et al (1990) A randomized trial of induction chemotherapy plus high-dose radiation alone in stage III non-small cell lung cancer. N Eng J Med 232:940-945
11. Edelman MJ, Gandara DR, Roach M, Benfield JR (1996) Multimodality therapy in stage III non-small cell lung cancer. Ann Thorac Surg 61:1564-1572
12. Edelman MJ, Bauer KS, Meiller T et al (2003) Phase I, pharmacokinetic (PK) and pharmacodynamic study of benzoylphenylurea (BPU, NSC 639829), a novel antitubulin agent. Proc Am Soc Clin Oncol 22:137
13. Furuse K, Fukuoka M, Kawahaa M et al (1999) Phase III study of concurrent versus sequential thoratic radiotherapy in combination with mitomycin, vindesine, and cis-platin in unresectable stage III non-small cell lung cancer. J Clin Oncol 17:2692-2699
14. Hinz JM, Yamada NA, Salazar EP et al (2005) Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells. DNA Repair 4:782-792
15. Karran P (2000) DNA double strand break repair in mammalian cells, Curr Opin Genet Dev 10:259-264
16. Komaki R, Scott CB, Sause WT et al (1997) Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Int J Radiat Biol Oncol Biol Phys 39:537-544
17. Mahrhofer H, B:rger S, Oppitz U et al (2006) Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assed by histone H2AX phosphorylation. Int J Radiat Oncol Biol Phys 64:573-580
18. Messersmith WA, Baker SD, Donehower RC et al (2003) Phase I study of continuous weekly dosing of dimethyl benzoylphenylurea in patients with solid tumors. Proc Am Soc Clin Oncol 22:203 (abstract #815)
19. Mountain CF (1997) Revisions in the international staging system for staging lung cancer. Chest 111:1710-1717
20. Nakajima T, Okamoto T, Masuda H et al (1990) Mechanism of tumor cell killing by HO-221, a novel antitumor compound. Cancer Chemother Pharmacol 27:199-204
21. National Cancer Institute Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment & Diagnosis (2000) Dimemethylamino benzoylphenylurea (NSC 639829): Preclinical pharmacology report
22. Pospiech H, Rytkönen AK, Syväoja JE (2001) The role of DNA polymerase in human non-homologous end joining. Nucleic Acids Res 29:3277-3788
23. Puck TT, Marcus PI (1956) Action of X-rays on mammalian cells. J Exp Med 103:653-606
24. Rogakou EP, Pilch DR, Orr AH et al (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858-5868
25. Rudek MA, Zhao M, Smith NF et al (2005) In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent. Clin Cancer Res 11:8503-8511
26. Saleh-Gohari N, Helleday T (2004) Conservative homologous recombination preferentially repairs DNA doublestrand breaks in the S phase of the cell cycle in human cells. Nucleic Acid Res 32:3683-3688
27. Sinclair WK (1968) Cyclic X-ray responses in mammalian cells in vitro. Radiat Res 33:620-643
28. Taneja N, Davis M, Choy JS et al (2004) Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279:2273-2280
29. Wang H, Wang X, Iliakis G et al (2003) Caffeine could not efficiently sensitize homologous recombination repair deficient cells to ionizing radiation-induced killing. Radiat Res 159:420-425
30. Wang X, Wang H, Iliakis G et al (2003) Caffeine-induced radiosensitization is independent of non-homologous end joining of DNA double strand breaks. Radiat Res 159:426-432